Chemokine System Changes Drive Age-Related Macular Degeneration and Influence Treatment Outcomes
Patients with nAMD with poor treatment response had dysregulation of the chemokine system. The chemokine system might be a potential target of novel treatment in nAMD. Further studies are needed to clarify the chemokine system's role in nAMD treatment response.
Authors
- Torben Lykke Sørensen (ORCID: https://orcid.org/0000-0002-6790-0199)
- Maria Abildgaard Steffensen (ORCID: https://orcid.org/0009-0008-6961-3055)
- Alexander Kai Thomsen (ORCID: https://orcid.org/0000-0002-0214-8020)
- Bent Honoré (ORCID: https://orcid.org/0000-0002-3459-7429)
- Henrik Vorum (ORCID: https://orcid.org/0000-0002-7600-0731)
- A. Nielsen (ORCID: https://orcid.org/0000-0001-8180-6871)
- Mogens Holst Nissen (ORCID: https://orcid.org/0000-0001-7729-8667)
Institutions
- University of Copenhagen (DK)
- Aarhus University (DK)
- Aalborg University Hospital (DK)
- Zealand University Hospital (DK)
- Aalborg University (DK)
Publication Details
- Journal
- Investigative Ophthalmology & Visual Science
- Published
- 2025-05-06
- DOI
- https://doi.org/10.1167/iovs.66.5.14
- Citations
- 2
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.41
Funders
- Velux Fonden
- Synoptik-Fonden
- Region Sjælland